Boc-O-benzyl-D-Serine

Boc-O-benzyl-D-Serine is a protected D-serine derivative bearing a Boc-protected amino group and an O-benzyl-protected side-chain hydroxyl, providing orthogonal protection suitable for controlled functional-group manipulation during peptide assembly. This stereochemically defined serine building block is used to introduce the D-Ser residue into peptide segments while minimizing undesired side reactions from the alcohol functionality. The combination of Boc and O-benzyl protection supports downstream deprotection strategies that preserve the peptide backbone while enabling selective side-chain handling for synthesis and derivatization workflows.

1. D-Ser Peptide Building Block

Boc-O-benzyl-D-Serine is used as a D-Ser amino acid building block for peptide synthesis where stereochemical control is required, including the preparation of D-amino acid-containing peptides for structure-function studies and peptidomimetic design. Peptide chemists commonly rely on the Boc-protected amino functionality to assemble defined sequences in segment coupling workflows, while the O-benzyl protection on the serine side chain suppresses alcohol reactivity during condensation and chain assembly. The resulting D-Ser incorporation is particularly valuable when researchers need to probe conformational effects, protease resistance trends, or backbone stereochemistry without introducing side-chain heterogeneity.

2. Orthogonally Protected Serine Derivatization

Boc-O-benzyl-D-Serine supports workflows that require controlled exposure of the serine side-chain hydroxyl at a later stage, enabling selective post-assembly modifications of D-serine residues. In custom peptide manufacturing and chemical biology projects, the O-benzyl group allows the serine alcohol to remain protected through peptide bond formation, then be addressed during downstream derivatization steps to generate serine-linked analogs for conjugation, tagging, or further functional group installation. This protection strategy is frequently chosen when the chemistry of the serine side chain must be staged to avoid competing reactions during earlier steps of peptide construction.

3. Peptidomimetic Intermediate Development

Boc-O-benzyl-D-Serine is also used as a protected intermediate for synthesizing D-serine-containing peptidomimetic fragments and specialized amino acid derivatives used in medicinal chemistry research. In small-molecule and peptide-small molecule hybrid programs, the protected amino and side-chain hydroxyl groups provide a stable platform for building defined stereochemical motifs that can be carried forward into coupling reactions or further elaboration. Researchers select this specific protection pattern when they need to maintain functional-group integrity during intermediate synthesis, then later unmask the appropriate functionality to enable attachment to adjacent scaffolds or to generate library members with consistent stereochemical identity.

4. Analytical Reference Peptide Synthesis

Boc-O-benzyl-D-Serine is used in the preparation of D-Ser-containing peptide standards and reference materials for analytical method development, including LC-MS characterization of peptide mixtures and method verification for peptide mapping workflows. Analytical groups often prefer D-amino acid-containing sequences because they provide distinct mass signatures and reduced ambiguity relative to proteinogenic peptide backgrounds, while the controlled protection during synthesis helps ensure reproducible product formation. By enabling reliable incorporation of the D-Ser residue into defined peptide standards, this building block supports downstream instrument qualification and comparative analysis across batches and experimental conditions.

1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

2. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII

3. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

4. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

5. A possible role of tachykinin-related peptide on an immune system activity of mealworm beetle, Tenebrio molitor L